Climb Bio (CLYM) Leases (2022 - 2026)
Climb Bio filings provide 5 years of Leases readings, the most recent being $447000.0 for Q1 2026.
- Quarterly Leases fell 0.89% to $447000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $447000.0 through Mar 2026, down 0.89% year-over-year, with the annual reading at $505000.0 for FY2025, 3.06% up from the prior year.
- Leases hit $447000.0 in Q1 2026 for Climb Bio, down from $505000.0 in the prior quarter.
- Across five years, Leases topped out at $807000.0 in Q1 2022 and bottomed at $12000.0 in Q3 2024.
- Average Leases over 5 years is $429176.5, with a median of $471000.0 recorded in 2022.
- The largest annual shift saw Leases plummeted 95.8% in 2024 before it surged 4583.33% in 2025.
- Climb Bio's Leases stood at $471000.0 in 2022, then tumbled by 57.75% to $199000.0 in 2023, then soared by 146.23% to $490000.0 in 2024, then increased by 3.06% to $505000.0 in 2025, then dropped by 11.49% to $447000.0 in 2026.
- Per Business Quant, the three most recent readings for CLYM's Leases are $447000.0 (Q1 2026), $505000.0 (Q4 2025), and $562000.0 (Q3 2025).